Article Sidebar

Download
PDF (Bahasa Indonesia)
Statistic
Read Counter : 1 Download : 0

Downloads

Download data is not yet available.

Main Article Content

Abstract

Chronic Kidney Disease (CKD) is a global health problem with rapidly increasing prevalence and high treatment costs. In developing countries, CKD management is more complex due to the influence of socioeconomic factors and underlying comorbidities. This study aims to obtain an overview of treatment costs and analyze the influence of patient characteristics, comorbidities, and length of stay on direct medical costs for CKD patients at Soerojo Hospital. This study was retrospective using data from CKD patients undergoing inpatient hemodialysis in 2024. Data collected included patient characteristics and direct medical costs. Data analysis was performed descriptively and inferentially using normality tests followed by non-parametric tests (Kruskal-Wallis and Mann-Whitney) to examine cost differences between groups. A total of 87 patients participated in this study. The majority of patients were male (57.74%) and aged ≥60 years (42.53%). Patients with stage 5 CKD dominated (87.36%), most of whom had 1–3 comorbidities (56.32%) with a length of stay ≤5 days (60.92%). The highest direct medical costs were found in patients with stage 5 CKD, especially in the cost of procedures (Rp13,422,222 ± 11,203,121). In general, the cost of procedures was the largest expenditure component. Based on statistical analysis, the variables of the number of comorbidities and length of hospitalization showed a significant relationship (p<.05) with the total cost of care for CKD patients. This study concluded that high clinical complexity due to comorbidities and long LOS were the main predictors of increased direct medical costs.

Keywords

Cost Analysis Hospitalization Direct Medical Costs

Article Details

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Author Biographies

Widarika Santi Hapsari, Program Studi Diploma Tiga Farmasi, Fakultas Ilmu Kesehatan, Universitas Muhammadiyah Magelang, Magelang, Indonesia

Program Studi Diploma Tiga Farmasi, Fakultas Ilmu Kesehatan, Universitas Muhammadiyah Magelang, Magelang, Indonesia

Nurfina Dian Kartikawati, Program Studi Pendidikan Profesi Apoteker, Fakultas Ilmu Kesehatan, Universitas Muhammadiyah Magelang, Magelang

Program Studi Pendidikan Profesi Apoteker, Fakultas Ilmu Kesehatan, Universitas Muhammadiyah Magelang, Magelang

Wahid Sabaan, Rumah Sakit Soerojo, Magelang, Indonesia

Rumah Sakit Soerojo, Magelang, Indonesia
How to Cite
Hapsari, W. S., Kartikawati, N. D., & Sabaan, W. (2026). Cost Analysis Pasien Chronic Kidney Diseases di Instalasi Rawat Inap RS Soerojo Magelang. Borneo Journal of Pharmascientech, 10(1), 383-391. https://doi.org/10.59053/bjp.v10i1.780
Download Citation
Endnote/Zotero/Mendeley (RIS)
BibTeX

References

  1. Abiyana, S. R., Santoso, S. B., Pribadi, P., Hapsari, W. S., & Syarifuddin, A. (2024). From the Drugbank Application to the Novel Drugs: A Pharmacogenomic Summary. E3S Web of Conferences, 500, 04002.
  2. Azalea, M., Andayani, T. M., & Satibi. (2016). Analisis Biaya Pengobatan Penyakit Ginjal Kronis Rawat Inap Dengan Hemodialisis Di Rumah Sakit. Jurnal Manajemen Dan Pelayanan Farmasi, 6(2), 141–150. https://doi.org/10.22146/jmpf.266
  3. BPJS Kesehatan. (2024). Laporan Pengelolaan Program Tahunan dan Laporan Keuangan 2023. BPJS Kesehatan. https://web.bpjs-kesehatan.go.id/uploads/information/05072024032036-d0e43b7b-4628-4963-8cb4-a2104605a2e6.pdf
  4. CDC. (2025, August 13). Chronic Kidney Disease in the United States, 2023. Chronic Kidney Disease. https://www.cdc.gov/kidney-disease/php/data-research/index.html
  5. Diwan, V., Hoy, W. E., Wang, Z., Zhang, J., Cameron, A., Venuthurupalli, S. K., Fassett, R. G., Chan, S., Healy, H. G., Tan, K.-S., Baer, R., Mallett, A. J., Gray, N., Mantha, M., Cherian, R., Mutatiri, C., Madhan, K., Kan, G., Mitchell, G., … Govindarajulu, S. (2023). Hospitalizations Among Adults With CKD in Public Renal Specialty Practices: A Retrospective Study From Queensland, Australia. Kidney Medicine, 5(9), 100700. https://doi.org/10.1016/j.xkme.2023.100700
  6. Dumaris, H. (2016). Analisis Perbedaan Tarif Rumah Sakit dan Tarif INA-CBG’s Pelayanan Rawat Jalan di RSUD Budhi Asih Jakarta Tahun 2015. Jurnal ARSI : Administrasi Rumah Sakit Indonesia, 3(1). https://doi.org/10.7454/arsi.v3i1.2209
  7. Francis, A., Harhay, M. N., Ong, A. C. M., Tummalapalli, S. L., Ortiz, A., Fogo, A. B., Fliser, D., Roy-Chaudhury, P., Fontana, M., Nangaku, M., Wanner, C., Malik, C., Hradsky, A., Adu, D., Bavanandan, S., Cusumano, A., Sola, L., Ulasi, I., & Jha, V. (2024). Chronic kidney disease and the global public health agenda: An international consensus. Nature Reviews Nephrology, 20(7), 473–485. https://doi.org/10.1038/s41581-024-00820-6
  8. Hadning, I., Hendrawan, H., & Rahayu, W. K. (2024). Cost of illness of chronic kidney disease patients with hemodialysis in Yogyakarta Indonesia. AIP Conference Proceedings, 3155(1).
  9. Hawthorne, G., Lightfoot, C. J., Smith, A. C., Khunti, K., & Wilkinson, T. J. (2023). Multimorbidity prevalence and patterns in chronic kidney disease: Findings from an observational multicentre UK cohort study. International Urology and Nephrology, 55(8), 2047–2057. https://doi.org/10.1007/s11255-023-03516-1
  10. Hustrini, N. M., Susalit, E., Widjaja, F. F., Khumaedi, A. I., Dekkers, O. M., van Diepen, M., & Rotmans, J. I. (2024). The Etiology of Advanced Chronic Kidney Disease in Southeast Asia: A Meta-analysis. Journal of Epidemiology and Global Health, 14(3), 740–764. https://doi.org/10.1007/s44197-024-00209-5
  11. Jadoul, M., Aoun, M., & Imani, M. M. (2024). The major global burden of chronic kidney disease. The Lancet Global Health, 12(3), e342–e343. https://doi.org/10.1016/S2214-109X(24)00050-0
  12. Jha, V., Al-Ghamdi, S. M. G., Li, G., Wu, M.-S., Stafylas, P., Retat, L., Card-Gowers, J., Barone, S., Cabrera, C., & Garcia Sanchez, J. J. (2023). Global Economic Burden Associated with Chronic Kidney Disease: A Pragmatic Review of Medical Costs for the Inside CKD Research Programme. Advances in Therapy, 40(10), 4405–4420. https://doi.org/10.1007/s12325-023-02608-9
  13. Jie, W., Yao, M., Wang, M., Wang, Y., Jia, Y., Liu, Y., Zou, K., & Sun, X. (2024). Analysis of the Economic Burden of Chronic Kidney Disease With Comorbidities Among Patients in Xuzhou, China. International Journal of Public Health, 69, 1607000. https://doi.org/10.3389/ijph.2024.1607000
  14. Kartikawati, N. D., Andayani, T. M., & Endarti, D. (2022). Cost Effectiveness Analysis (CEA) Strategi Terapi Anemia pada Pasien Penyakit Ginjal Kronis. JURNAL MANAJEMEN DAN PELAYANAN FARMASI (Journal of Management and Pharmacy Practice), 12(3), Article 3. https://doi.org/10.22146/jmpf.72614
  15. Kovesdy, C. P. (2022). Epidemiology of chronic kidney disease: An update 2022. Kidney International Supplements, 12(1), 7–11. https://doi.org/10.1016/j.kisu.2021.11.003
  16. Liyanage, T., Toyama, T., Hockham, C., Ninomiya, T., Perkovic, V., Woodward, M., Fukagawa, M., Matsushita, K., Praditpornsilpa, K., Hooi, L. S., Iseki, K., Lin, M.-Y., Stirnadel-Farrant, H. A., Jha, V., & Jun, M. (2022). Prevalence of chronic kidney disease in Asia: A systematic review and analysis. BMJ Global Health, 7(1). https://doi.org/10.1136/bmjgh-2021-007525
  17. MacRae, C., Mercer, S. W., Guthrie, B., & Henderson, D. (2021). Comorbidity in chronic kidney disease: A large cross-sectional study of prevalence in Scottish primary care. The British Journal of General Practice, 71(704), e243–e249. https://doi.org/10.3399/bjgp20X714125
  18. Makmun, A., Satirapoj, B., Tuyen, D. G., Foo, M. W. Y., Danguilan, R., Gulati, S., Kim, S., Bavanandan, S., Chiu, Y.-W., & Tang, S. C. W. (2024). The burden of chronic kidney disease in Asia region: A review of the evidence, current challenges, and future directions. Kidney Research and Clinical Practice, 44(3), 411–433. https://doi.org/10.23876/j.krcp.23.194
  19. Mariani, L., Nurmainah, N., & Rizkifani, S. (2024). Analisis Biaya Medis Langsung Pasien Hepatitis B Kronik Rawat Jalan di RSUD Sultan Syarif Mohamad Alkadrie Kota Pontianak. Jurnal Pharmascience, 11(1), 1–14. https://doi.org/10.20527/jps.v11i1.16054
  20. Neugarten, J., & Golestaneh, L. (2019). Influence of Sex on the Progression of Chronic Kidney Disease. Mayo Clinic Proceedings, 94(7), 1339–1356. https://doi.org/10.1016/j.mayocp.2018.12.024
  21. Putri, E. M., Tandela, T., Mawarni, O. I., Dhafin, A. A., & Prasetyawan, F. (2025). Analysis of Direct Medical Costs in Hemodialysis Patients. International Journal of Asian Business and Development, 1(1), 71-80-71–80.
  22. Ricardo, A. C., Yang, W., Sha, D., Appel, L. J., Chen, J., Krousel-Wood, M., Manoharan, A., Steigerwalt, S., Wright, J., Rahman, M., Rosas, S. E., Saunders, M., Sharma, K., Daviglus, M. L., & Lash, J. P. (2019). Sex-Related Disparities in CKD Progression. Journal of the American Society of Nephrology : JASN, 30(1), 137–146. https://doi.org/10.1681/ASN.2018030296
  23. Rosmila, G. B., Yaya, R., & Pribadi, F. (2020). The comparison of the unit cost of hemodialysis with ina cbg rates in Muhammadiyah Siti Aminah Hospital. Archives of Business Research, 8(5), Article 5. https://doi.org/10.14738/abr.85.8210
  24. Sari, S., Suhada, Z., & Triagustini, T. (2023). Cost of illness pasien gagal ginjal kronis di Rumah Sakit Umum Daerah Arifin Achmad Provinsi Riau. Jurnal Ilmiah Farmasi, 19(2), Article 2. https://doi.org/10.20885/jif.vol19.iss2.art10
  25. Smith, D. H., Gullion, C. M., Nichols, G., Keith, D. S., & Brown, J. B. (2004). Cost of Medical Care for Chronic Kidney Disease and Comorbidity among Enrollees in a Large HMO Population. Journal of the American Society of Nephrology, 15(5), 1300–1306. https://doi.org/10.1097/01.ASN.0000125670.64996.BB
  26. Sunariyanti, E., Andayani, T. M., Endarti, D., & Puspandari, D. A. (2023a). Cost Analysis of Chronic Kidney Disease Patients in Indonesia. ClinicoEconomics and Outcomes Research: CEOR, 15, 621–629. https://doi.org/10.2147/CEOR.S388547
  27. Sunariyanti, E., Andayani, T. M., Endarti, D., & Puspandari, D. A. (2023b). Cost Analysis of Chronic Kidney Disease Patients in Indonesia. ClinicoEconomics and Outcomes Research, 15, 621–629. https://doi.org/10.2147/CEOR.S388547
  28. Suriyong, P., Ruengorn, C., Shayakul, C., Anantachoti, P., & Kanjanarat, P. (2022). Prevalence of chronic kidney disease stages 3–5 in low- and middle-income countries in Asia: A systematic review and meta-analysis. PLOS ONE, 17(2), e0264393. https://doi.org/10.1371/journal.pone.0264393
  29. Tang, Y., Jiang, J., Zhao, Y., & Du, D. (2024). Aging and chronic kidney disease: Epidemiology, therapy, management and the role of immunity. Clinical Kidney Journal, 17(9), sfae235. https://doi.org/10.1093/ckj/sfae235
  30. Yani, F. R. W. P. F., Mukti, A. G., & Sudjaswadi, R. (2011). Cost Analysis Of Chronic Kidney Disease Treatment Inpatient As Consideration Determination In Health Financing Based On INA-DRG In Dr Moewardi Hospital. Jurnal Manajemen Dan Pelayanan Farmasi (Journal of Management and Pharmacy Practice), 1(2), Article 2. https://doi.org/10.22146/jmpf.32